North Suffolk Neurology Research Foundation is seeking new participants to advance the treatment of a wide range of neurological diseases.
Movement & Neuromuscular Disorders Research
Coming soon
Headache Disorders Research
Current Clinical Trials
- Tian Medical LLC- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel, 20 Week Study of Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine (Protocol 16-001TI)
- Biohaven Pharmaceuticals, Inc.- A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention (Protocol BHV3500-302)
- Biohaven Pharmaceuticals, Inc.- Phase 3, Multicenter, Randomized, Double-Blind, Group Sequential, Placebo-Controlled Study to Assess Efficacy and Safety of Rimegepant for the Treatment of Migraine (with or without aura) in Children and Adolescents 6-18 Years of Age (Protocol BHV3000-311)
- Biohaven Pharmaceuticals, Inc.- Phase 3, Multicenter, Open-Label Study to Assess the Long-Term Safety and Tolerability of Rimegepant for the Acute Treatment of Migraine (with or without aura) in Children and Adolescents 6-18 Years of Age (Protocol BHV3000-312)
- Satsuma Pharmaceuticals, Inc- A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine (Protocol STS101-007)
Multiple Sclerosis Research
Coming soon
Neuromuscular Disorders Research
Interested in participating in a clinical trial?
North Suffolk Neurology Research Foundation is seeking new participants to advance and treat neurological diseases and disorders.
Current Clinical Trials
- PrecisionMed, INC.- A single or Multiple Visit Protocol for Collection DNA/RNA/SERUM/PLASMA/CSF in Amyotrophic Lateral Sclerosis (ALS) and Related Disorders (Protocol 4800)
Memory Disorders Research
Coming soon
Sleep Disorders Research
Coming soon
Cerebrovascular & Seizure Disorders Research
Coming soon
Nerve Pain & Other Pain Disorders
Current Clinical Trials
- Biohaven Pharmaceuticals Holding Company Limited- Phase 2: Double-Blind, Placebo Controlled, Crossover Trial of BHV-3000 (Rimegepant) for Treatment Refractory Trigeminal Neuralgia (Protocol BHV3000-202)
If you wish to be advised on the most appropriate treatment, please call to schedule an appointment or click to request an appointment online.
